LncRNA MEG3 Inhibits the Epithelial-mesenchymal Transition of Bladder Cancer Cells through the Snail/E-cadherin Axis

Abstract

Objective

This study aimed to investigate the role of the long noncoding RNA (lncRNA) maternally expressed gene 3 (MEG3) in the epithelial-mesenchymal transition (EMT) of bladder cancer cells and the potential mechanisms.

Methods

Cell invasion, migration, and wound healing assays were conducted to assess the effects of MEG3 on the invasive and migratory capabilities of bladder cancer cells. The expression levels of E-cadherin were measured using Western blotting, RT-qPCR, and dual luciferase reporter assays. RNA immunoprecipitation and pull-down assays were performed to investigate the interactions between MEG3 and its downstream targets.

Results

MEG3 suppressed the invasion and migration of bladder cancer cells and modulated the transcription of E-cadherin. The binding of MEG3 to the zinc finger region of the transcription factor Snail prevented its ability to transcriptionally repress E-cadherin. Additionally, MEG3 suppressed the phosphorylation of extracellular regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), and P38, thereby decreasing the expression of Snail and stimulating the expression of E-cadherin.

Conclusion

MEG3 plays a vital role in suppressing the EMT in bladder cancer cells, indicating its potential as a promising therapeutic target for the treatment of bladder cancer.

References

[1] Sung H, Ferlay J, Siegel RL, et al.. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021, 71(3): 209-249

[2] Cai Q, Chen Y, Xin S, et al.. Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030. Transl Androl Urol, 2020, 9(2): 153-165

[3] Kamat AM, Hahn NM, Efstathiou JA, et al.. Bladder cancer. Lancet, 2016, 388(10061): 2796-2810

[4] Isharwal S, Konety B. Non-muscle invasive bladder cancer risk stratification. Indian J Urol, 2015, 31(4): 289-296

[5] Zhang J, Gao Y. Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination. Cancer Cell Int, 2019, 19: 175

[6] Gong A, Zhao X, Pan Y, et al.. The lncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation. J Cell Sci, 2020, 133(16): jcs244020

[7] Shan G, Tang T, Xia Y, et al.. MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN. J Cell Physiol, 2020, 235(2): 1120-1128

[8] Ying L, Huang Y, Chen H, et al.. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst, 2013, 9(3): 407-411

[9] Huang C, Liao X, Jin H, et al.. MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion. Mol Ther Nucleic Acids, 2019, 16: 51-62

[10] Terashima M, Tange S, Ishimura A, et al.. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines. J Biol Chem, 2017, 292(1): 82-99

[11] Li J, Jiang X, Li C, et al.. LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma. J Cell Physiol, 2019, 234(12): 22947-22959

[12] Wang M, Tu Y, Liu C, et al.. Gambogenic Acid Inhibits Invasion and Metastasis of Melanoma through Regulation of lncRNA MEG3. Biol Pharm Bull, 2023, 46(10): 1385-1393

[13] Pastushenko I, Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol, 2019, 29(3): 212-226

[14] De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer, 2013, 13(2): 97-110

[15] Luo G, Liu D, Huang C, et al.. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27(Kip1). Mol Cancer Res, 2017, 15(7): 789-799

[16] Wang M, Guo C, Wang L, et al.. Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. Cell Death Dis, 2018, 9(2): 238

[17] Stemmler MP, Eccles RL, Brabletz S, et al.. Non-redundant functions of EMT transcription factors. Nat Cell Biol, 2019, 21(1): 102-112

[18] Imani S, Hosseinifard H, Cheng J, et al.. Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Sci Rep, 2016, 6: 28587

[19] Vesuna F, van Diest P, Chen JH, et al.. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun, 2008, 367(2): 235-241

[20] Schneider G, Kramer OH, Saur D. A ZEB1-HDAC pathway enters the epithelial to mesenchymal transition world in pancreatic cancer. Gut, 2012, 61(3): 329-330

[21] Comijn J, Berx G, Vermassen P, et al.. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell, 2001, 7(6): 1267-1278

[22] Cano A, Perez-Moreno MA, Rodrigo I, et al.. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol, 2000, 2(2): 76-83

[23] Bhan A, Mandal SS. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem, 2014, 9(9): 1932-1956

[24] Wang Y, Shi J, Chai K, et al.. The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug Targets, 2013, 13(9): 963-972

[25] Liu ZC, Chen XH, Song HX, et al.. Snail regulated by PKC/GSK-3beta pathway is crucial for EGF-induced epithelial-mesenchymal transition (EMT) of cancer cells. Cell Tissue Res, 2014, 358(2): 491-502

[26] Cicenas J, Zalyte E, Rimkus A, et al.. JNK, p38, ERK, and SGK1 Inhibitors in Cancer. Cancers (Basel), 2017, 10(1): 1

[27] Wang X, Li X, Wang Z. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes. Oncol Rep, 2021, 45(4): 40

[28] Zhan H, Chang X, Wang X, et al.. LncRNA MEG3 mediates nickel oxide nanoparticles-induced pulmonary fibrosis via suppressing TGF-beta1 expression and epithelial-mesenchymal transition process. Environ Toxicol, 2021, 36(6): 1099-1110

[29] Dill TL, Carroll A, Pinheiro A, et al.. The long noncoding RNA Meg3 regulates myoblast plasticity and muscle regeneration through epithelial-mesenchymal transition. Development, 2021, 148(2): dev194027

[30] Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol, 2019, 20(2): 69-84

[31] Kaszak I, Witkowska-Pilaszewicz O, Niewiadomska Z, et al.. Role of Cadherins in Cancer-A Review. Int J Mol Sci, 2020, 21(20): 7624

[32] Mendonsa AM, Na TY, Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene, 2018, 37(35): 4769-4780

[33] Pan Y, Li J, Zhang Y, et al.. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression. Sci Rep, 2016, 6: 25798

[34] Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci, 1999, 24(2): 73-76

[35] Canel M, Serrels A, Frame MC, et al.. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci, 2013, 126: 393-401 Pt 2)

[36] Lin Y, Dong C, Zhou BP. Epigenetic regulation of EMT: the Snail story. Curr Pharm Des, 2014, 20(11): 1698-1705

[37] Zhu J, Liu S, Ye F, et al.. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells. PLoS One, 2015, 10(10): e0139790

[38] Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol, 2002, 3(3): 155-166

[39] Dominguez D, Montserrat-Sentis B, Virgos-Soler A, et al.. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol Cell Biol, 2003, 23(14): 5078-5089

[40] Schulte J, Weidig M, Balzer P, et al.. Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol, 2012, 138(6): 847-860

[41] Santi R, Cai T, Nobili S, et al.. Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study. Virchows Arch, 2018, 472(4): 605-613

[42] Yan Y, Bao G, Pei J, et al.. NF-kappaB and EGFR participate in S1PR3-mediated human renal cell carcinomas progression. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(7): 166401

[43] Peng B, He R, Xu Q, et al.. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway. Pharmacol Res, 2019, 142: 1-13

[44] Lee Y, Ko D, Yoon J, et al.. TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity. J Exp Clin Cancer Res, 2021, 40(1): 58